NCT06771739 2026-03-13
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
Clinical Trials
17 trialsNCT07438093 2026-02-27
Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors
The First Affiliated Hospital of Xiamen University
Phase NA Not yet recruiting
NCT07141407 2026-02-11
Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT07396090 2026-02-09
Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
NCT06772090 2026-02-03
Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies
Masonic Cancer Center, University of Minnesota
Phase NA Not yet recruiting
NCT07278739 2025-12-12
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
SWOG Cancer Research Network
Phase NA Not yet recruiting
NCT07274657 2025-12-10
SMILE
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase NA Not yet recruiting
NCT07155811 2025-09-04
T-ECHNICO
Centre Leon Berard
Phase NA Not yet recruiting
NCT06971848 2025-07-11
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT06889675 2025-03-21
First in Human Study of YB1-X7 Injection
Shanghai Salvectors Biotechnology LTD.
Phase NA Not yet recruiting
NCT06524024 2025-02-10
DC-CTL
Zhengzhou Revo-Gene Technology Co., LTD
Phase NA Not yet recruiting
NCT06310993 2024-12-03
BICEP
Sheffield Teaching Hospitals NHS Foundation Trust
Phase NA Not yet recruiting
NCT06541301 2024-11-19
PICCHEST
European Institute of Oncology
Phase NA Not yet recruiting
NCT06649448 2024-10-18
EF-001
Shandong Cancer Hospital and Institute
Phase NA Not yet recruiting
NCT06245018 2024-02-07
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Nuwacell Biotechnologies Co., Ltd.
Phase NA Not yet recruiting
NCT06156332 2023-12-05
A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
Shanghai Changzheng Hospital
Phase NA Not yet recruiting
NCT05949775 2023-07-18
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Stemirna Therapeutics
Phase NA Not yet recruiting